申请人:Donde Yariv
公开号:US20050228185A1
公开(公告)日:2005-10-13
A compound comprising
or a pharmaceutically acceptable salt or a prodrug thereof, wherein the dashed line represents the presence or absence of a double bond; J is C═O or CHOH;
A is —(CH
2
)
6
—, or cis —CH
2
CH═CH—(CH
2
)
3
—, wherein 1 or 2 carbons may be substituted with S or O;
B is CO
2
H, or CO
2
R, CONR
2
, CONHCH
2
CH
2
OH, CON(CH
2
CH
2
OH)
2
, CH
2
OR, P(O)(OR)
2
, CONRSO
2
R, SONR
2
, or
R is H, C
1-6
alkyl;
D is —(CH
2
)
n
—, —X(CH
2
)
n
, or —(CH
2
)
n
X—, wherein n is from 0 to 3 and X is S or O; and
E is an aromatic or heteroaromatic moiety having from 0 to 4 substituents, said substituents each comprising from 1 to 6 non-hydrogen atoms is disclosed herein. Methods, compositions, and medicaments related thereto, as well as experimental results showing prostaglandin EP
4
selective agonist activity for certain compounds disclosed herein, are also disclosed.
本发明涉及一种化合物,其包括或其药学上可接受的盐或其前药,其中虚线表示双键的存在或缺失;J为C═O或CHOH;A为—(CH2)6—,或顺式—CH2CH═CH—(CH2)3—,其中1或2个碳原子可被S或O取代;B为CO2H,或CO2R,CONR2,CONHCH2CH2OH,CON(CH2CH2OH)2,CH2OR,P(O)(OR)2,CONRSO2R,SONR2,或R为H,C1-6烷基;D为—(CH2)n—,—X(CH2)n,或—(CH2)nX—,其中n为0至3,X为S或O;和E为芳香或杂芳基,其具有0至4个取代基,所述取代基每个包含1至6个非氢原子。本发明还涉及与之相关的方法、组合物和药物,以及实验结果显示某些本发明所披露的化合物具有前列腺素EP4选择性激动剂活性。